Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial

Luymes, C.H.; Poortvliet, R.K.E.; Geloven, N. van; Waal, M.W.M. de; Drewes, Y.M.; Blom, J.W.; ... ; Numans, M.E. (2018)

Article / Letter to editor

• General practice
• Preventive medicine
• Cardiovascular disease
• Antihypertensive agent
• Anticholesteremic agent
• Inappropriate prescribing

• All authors: Luymes, C.H.; Poortvliet, R.K.E.; Geloven, N. van; Waal, M.W.M. de; Drewes, Y.M.; Blom, J.W.; Smidt, N.; Assendelft, W.J.J.; Hout, W.B. van den; Ruijter, W. de; Numans, M.E.
• Date: 2018-01-11
• Journal: BMC Medicine
• Volume: 16
• DOI: doi:10.1186/s12916-017-0988-0